Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1116
-
Total 13F shares, excl. options
-
246M
-
Shares change
-
-5.55M
-
Total reported value, excl. options
-
$20.3B
-
Value change
-
-$536M
-
Put/Call ratio
-
0.65
-
Number of buys
-
482
-
Number of sells
-
-552
-
Price
-
$82.45
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q1 2020
1,264 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q1 2020.
NOVARTIS AG - Ordinary Shares (NVS) has 1,116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 246M shares
of 2.18B outstanding shares and own 11.27% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (24M shares), Dodge & Cox (22.9M shares), LOOMIS SAYLES & CO L P (10.4M shares), FRANKLIN RESOURCES INC (8.88M shares), BANK OF AMERICA CORP /DE/ (8.65M shares), Fisher Asset Management, LLC (8.53M shares), RENAISSANCE TECHNOLOGIES LLC (8.49M shares), Mawer Investment Management Ltd. (7.72M shares), UBS Group AG (7.4M shares), and WELLS FARGO & COMPANY/MN (6.64M shares).
This table shows the top 1116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.